Does TNF-driven inflammatory signaling activate phospholipase A2 and increase eicosanoid production?

Tumor necrosis factor (TNF)-driven inflammatory signaling plays a crucial role in initiating and sustaining cellular inflammatory cascades by mobilizing lipid mediators.

Mechanistic activation of phospholipase A2

• Kinase phosphorylation: TNF-alpha binding to its receptor (primarily TNFR1) robustly activates mitogen-activated protein kinase (MAPK) cascades, including ERK, p38, and JNK. These kinases directly phosphorylate cytosolic phospholipase A2 (cPLA2) at regulatory serine residues, such as Ser505, which drastically elevates its catalytic activity.
• Membrane translocation: Alongside kinase activation, TNF-induced calcium ($\text{Ca}^{2+}$) mobilization triggers the physical translocation of cPLA2 to intracellular membranes.
• Arachidonic acid release: Once localized to the membrane, activated cPLA2 selectively hydrolyzes the sn-2 position of membrane phospholipids. This enzymatic cleavage acts as the rate-limiting step that releases free arachidonic acid into the cell.

Downstream eicosanoid synthesis

• Enzymatic conversion: TNF-alpha signaling simultaneously induces the expression of cyclooxygenase-2 (COX-2).
• Eicosanoid production: The newly liberated arachidonic acid serves as the direct substrate for COX-2 and lipoxygenase (LOX) pathways, resulting in a robust increase in downstream pro-inflammatory eicosanoids, such as prostaglandin E2 ($\text{PGE}_2$). Conversely, pharmacological inhibition of cPLA2 effectively blocks both arachidonic acid release and subsequent eicosanoid generation.

Bottom line

• TNF-alpha signaling drives a highly coordinated inflammatory cascade, activating cPLA2 via MAPK phosphorylation and calcium-mediated translocation to release membrane arachidonic acid, which directly fuels downstream pro-inflammatory eicosanoid production.